Background: Epileptic seizures have been reported in Wilson's disease (WD) in 6–7% of patients,
mostly following the chelator therapy. Pyridoxine deficiency due to penicillamine,
direct copper toxicity, pathological changes, metabolic encephalopathy and rarely
copper deficiency are the attributed mechanisms for seizures.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2013 Published by Elsevier Inc.
